AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 295: E705-E713, 2008. First published July 22, 2008; doi:10.1152/ajpendo.90338.2008
0193-1849/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
295/3/E705    most recent
90338.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Yamashita, H.
Right arrow Articles by Goldberg, I. J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamashita, H.
Right arrow Articles by Goldberg, I. J.

Cardiac metabolic compensation to hypertension requires lipoprotein lipase

Haruyo Yamashita,1 Kalyani G. Bharadwaj,1 Shota Ikeda,1 Tae-Sik Park,2 and Ira J. Goldberg1

1Divisions of Preventive Medicine and Nutrition, and Cardiology, Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York; 2Department of Medicine, Lee Gil Ya Cancer and Diabetes Institute, and Gachon University, Incheon, Korea

Submitted 5 April 2008 ; accepted in final form 10 July 2008

Fatty acids (FAs) are acquired from free FA associated with albumin and lipoprotein triglyceride that is hydrolyzed by lipoprotein lipase (LpL). Hypertrophied hearts shift their substrate usage pattern to more glucose and less FA. However, FAs may still be an important source of energy in hypertrophied hearts. The aim of this study was to examine the importance of LpL-derived FAs in hypertensive hypertrophied hearts. We followed cardiac function and metabolic changes during 2 wk of angiotensin II (ANG II)-induced hypertension in control and heart-specific lipoprotein lipase knockout (hLpL0) mice. Glucose metabolism was increased in ANG II-treated control (control/ANG II) hearts, raising it to the same level as hLpL0 hearts. FA uptake-related genes, CD36 and FATP1, were reduced in control/ANG II hearts to levels found in hLpL0 hearts. ANG II did not alter these metabolic genes in hLpL0 mice. LpL activity was preserved, and mitochondrial FA oxidation-related genes were not altered in control/ANG II hearts. In control/ANG II hearts, triglyceride stores were consumed and reached the same levels as in hLpL0/ANG II hearts. Intracellular ATP content was reduced only in hLpL0/ANG II hearts. Both ANG II and deoxycorticosterone acetate-salt induced hypertension caused heart failure only in hLpL0 mice. Our data suggest that LpL activity is required for normal cardiac metabolic compensation to hypertensive stress.

hypertrophy; heart failure; fatty acids; triglyceride; angiotensin II; deoxycorticosterone acetate



Address for reprint requests and other correspondence: I. J. Goldberg, Dept. of Medicine, Columbia University, 630 West 168thSt., New York, NY 10032 (e-mail: ijg3{at}columbia.edu)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.